Trials / Completed
CompletedNCT02506387
Belgian Mitraclip Registry
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 520 (actual)
- Sponsor
- Universiteit Antwerpen · Academic / Other
- Sex
- All
- Age
- 25 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the registry is to investigate and follow all patients treated with the MitraClip System in Belgium. This information is intended to contribute to decision making with regards to MitraClip therapy selection in patients with mitral regurgitation: (a) by establishing the clinical value of the MitraClip therapy in the continuum of care; and (b) by providing practical information that will allow physicians to make therapeutic decisions, assist hospitals to make purchasing decisions, and assist insurers/government in making coverage decisions. In addition national data will be shared with European registries in order to increase the knowledge about the efficacy of this new technique.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | mitraclip | The decision to implant mitraclip is not part of this observational study but is made by the heart-team. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2023-01-01
- Completion
- 2024-12-01
- First posted
- 2015-07-23
- Last updated
- 2025-07-18
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02506387. Inclusion in this directory is not an endorsement.